Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

519.51
+4.070.79%
Post-market: 519.510.00000.00%19:56 EDT
Volume:837.11K
Turnover:434.51M
Market Cap:131.81B
PE:30.24
High:525.29
Open:522.17
Low:514.66
Close:515.44
52wk High:560.25
52wk Low:374.17
Shares:253.72M
Float Shares:253.72M
Volume Ratio:0.92
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.18
EPS(LYR):15.32
ROE:23.54%
ROA:11.93%
PB:6.51
PE(LYR):33.91

Loading ...

Major Deals Involving US Drugmakers and Biotechs over the Past Decade

Reuters
·
Jul 07

Deals of the Day-mergers and Acquisitions

Reuters
·
Jul 07

Why Is Crinetics Stock (CRNX) Surging Nearly 100% in Pre-Market Today, 7/7/26? Analysts React

TIPRANKS
·
Jul 07

Vertex’s $10 Billion Crinetics Acquisition Adds Endocrinology Growth Pillars, Supporting Long-Term Buy Thesis

TIPRANKS
·
Jul 07

Vertex to Buy Crinetics for $10 Billion in Rare-Diseases Push

Reuters
·
Jul 07

Vertex Minerals Launches $0.10 Share Purchase Plan for Existing Investors

TIPRANKS
·
Jul 07

PRESS Digest -wall Street Journal - July 7

Reuters
·
Jul 07

Crinetics downgraded to Neutral from Overweight at Cantor Fitzgerald

TIPRANKS
·
Jul 07

Dow Jones Top Company Headlines at 9 PM ET: Samsung Expects Another Record Quarter on Robust AI Chip Demand | Walmart ...

Dow Jones
·
Jul 07

Vertex to Acquire Crinetics in $10 Billion Merger

TIPRANKS
·
Jul 07

M&A News: Vertex Stock (VRTX) Slips After Announcing $10B Crinetics Acquisition

TIPRANKS
·
Jul 07

Crinetics Pharmaceuticals - Co May Pay Termination Fee of $350.47 Mln to Vertex if Deal is Terminated Under Certain Circumstances - SEC Filing

THOMSON REUTERS
·
Jul 07

Crinetics Shares More than Doubles in After Market Trade After Vertex Announces $10 Billion Acquisition Deal, Last up 101% at $84.80

THOMSON REUTERS
·
Jul 07

Vertex EVP, Chief Legal Officer Joy Liu Sells 828 Vertex Shares Worth $416,243.88

Reuters
·
Jul 07

Vertex to acquire Crinetics for $85 per share in cash

TIPRANKS
·
Jul 07

Vertex to Buy Crinetics for USD 85 Per Share in USD 10 Billion Deal

Reuters
·
Jul 07

Crinetics Pharmaceuticals: Financing Supported by $4.5 Bln of Fully Committed Bridge Financing from Bank of America, Morgan Stanley Senior Funding

THOMSON REUTERS
·
Jul 07

Crinetics Pharmaceuticals: Deal Expected to be Accretive Vertex's to Non-gaap Operating Income in 2029

THOMSON REUTERS
·
Jul 07

Crinetics Pharmaceuticals Inc: Vertex Will Acquire Crinetics for $85.00 Per Share in Cash

THOMSON REUTERS
·
Jul 07

Vertex Signs LOI with Pcpa for Alyftrek in Cystic Fibrosis Treatment

Reuters
·
Jul 06